We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-11.59%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.6B
AUM Growth
-$3.29B
Cap. Flow
-$1.2B
Cap. Flow %
-8.83%
Top 10 Hldgs %
51.07%
Holding
116
New
14
Increased
50
Reduced
18
Closed
20

Top Buys

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$538M
2
RHT
Red Hat Inc
RHT
+$426M
3
AABA
Altaba Inc
AABA
+$393M
4
CI icon
Cigna
CI
+$220M
5
EQIX icon
Equinix
EQIX
+$196M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$1.51B
2
ESRX
Express Scripts Holding Company
ESRX
+$1.13B
3
COL
Rockwell Collins
COL
+$584M
4
DELL icon
Dell
DELL
+$430M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$257M

Sector Composition

Rank Sector Weight
1 Communication Services 23.71%
2 Healthcare 20.15%
3 Technology 18.04%
4 Industrials 7.34%
5 Consumer Discretionary 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
51
Exelixis
EXEL
$13.8B
$39.3M 0.29%
2,000,000
+920,000
+85% +$16.4M
RETA
52
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$39.3M 0.29%
700,000
+26,500
+4% +$1.62M
NXPI icon
53
NXP Semiconductors
NXPI
$59B
$39.2M 0.29%
535,000
-1,115,000
-68% -$88.3M
SAGE
54
DELISTED
Sage Therapeutics
SAGE
$38.3M 0.28%
400,000
-225,000
-36% -$25.7M
CRSP icon
55
CRISPR Therapeutics
CRSP
$5.06B
$35.7M 0.26%
1,250,000
+231,406
+23% +$8.04M
KYNB
56
Kyntra Bio
KYNB
$28.1M
$34.7M 0.25%
30,000
-25,800
-46% -$29M
RDUS
57
DELISTED
Radius Health, Inc.
RDUS
$33.7M 0.25%
2,043,149
– –
BPY
58
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$33.4M 0.25%
2,075,000
+1,280,618
+161% +$23.4M
RC
59
Ready Capital
RC
$276M
$30.5M 0.22%
2,203,239
– –
ORBK
60
DELISTED
Orbotech Ltd
ORBK
$30.3M 0.22%
535,721
+305,721
+133% +$17.1M
FATE icon
61
Fate Therapeutics
FATE
$296M
$28.2M 0.21%
2,200,000
+1,670,000
+315% +$23.3M
PTCT icon
62
PTC Therapeutics
PTCT
$5.86B
$24M 0.18%
700,000
+280,000
+67% +$10.1M
ZYME icon
63
Zymeworks
ZYME
$1.72B
$23.1M 0.17%
1,575,000
+240,000
+18% +$3.15M
CDXS icon
64
Codexis
CDXS
$160M
$19.3M 0.14%
1,155,000
+155,000
+16% +$2.68M
ARWR icon
65
Arrowhead Research
ARWR
$12.2B
$18.6M 0.14%
+1,500,000
New +$20.5M
SVRA icon
66
Savara
SVRA
$1.16B
$18.4M 0.13%
2,425,000
+6,991
+0.3% +$62.9K
DVAX
67
DELISTED
Dynavax Technologies
DVAX
$18.3M 0.13%
2,000,000
+930,000
+87% +$10.3M
BUD icon
68
AB InBev
BUD
$167B
$18.2M 0.13%
275,843
-17,266
-6% -$1.32M
CLVS
69
DELISTED
Clovis Oncology, Inc.
CLVS
$18M 0.13%
+1,000,000
New +$20.4M
PGNX
70
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$17.6M 0.13%
4,200,820
+588,000
+16% +$2.99M
CCXI
71
DELISTED
ChemoCentryx, Inc.
CCXI
$15.8M 0.12%
1,450,000
+300,000
+26% +$3.16M
SHPG
72
DELISTED
Shire pic
SHPG
$15.2M 0.11%
87,000
– –
PTGX icon
73
Protagonist Therapeutics
PTGX
$9.32B
$14.8M 0.11%
2,199,674
-43,528
-2% -$345K
QTNT
74
DELISTED
Quotient Limited Ordinary Shares
QTNT
$14.7M 0.11%
+60,000
New +$15.7M
BMS
75
DELISTED
Bemis
BMS
$14.5M 0.11%
316,160
+109,500
+53% +$5.1M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Farallon Capital Management held 116 positions worth $13.6B, down 19% from $16.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management withdrew a net $1.2B in Q4 2018, closing 20 positions and reducing 18 holdings. Its most notable exit was Aetna Inc, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Farallon Capital Management opened a new position in Red Hat Inc worth $472M.

  • Farallon Capital Management's largest Q4 2018 buy was Red Hat Inc: 2,685,000 shares worth $472M.
  • Farallon Capital Management added most to Twenty-First Century Fox, Inc. Class A in Q4 2018, an estimated $538M increase.
  • Farallon Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $430M.
  • Farallon Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $1.51B.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.6B portfolio in Q4 2018.
  • Farallon Capital Management opened 14 new positions and closed 20 in Q4 2018.
  • Farallon Capital Management's portfolio value fell 19% quarter-over-quarter to $13.6B.

Based on Farallon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.